Neoadjuvant chemo-immunotherapy following concurrent immuno-chemoradiotherapy and immune-maintenance therapy as primary treatment for locally advanced cervical cancer: A prospective, single-arm, phase 2 trial.

Fo-Ping Chen(Sun Yat-sen University), Weijun Ye(Sun Yat-sen University), Kai Chen(Hong Kong University of Science and Technology), Yi Ouyang(Sun Yat-sen University), Hai-Ying Wu(Sun Yat-sen University), Lin Huang(Sun Yat-sen University), Xiaodan Huang(Guangzhou University of Chinese Medicine)
Journal of Clinical Oncology
June 1, 2024
Cited by 1


Related Papers